JPMorgan (NYSE: JPM) insider plans Rule 144 sale of 3,404 shares
Rhea-AI Filing Summary
JPMorgan Chase insider Stacey Friedman has filed a Form 144 indicating an intent to sell 3,404 shares of common stock. The planned sale, through J.P. Morgan Securities LLC on the NYSE, has an aggregate market value of 1,042,985.11 based on the filing.
The shares to be sold were originally acquired on 03/25/2022 as equity compensation awards from the issuer. The filing also notes a prior sale of 3,404 shares of common stock on 01/16/2026, which generated gross proceeds of 1,064,758. Shares outstanding were 2,696,272,576 as of the figures used in the notice.
Positive
- None.
Negative
- None.
Insights
Routine Form 144 for a modest insider share sale relative to JPMorgan’s size.
This notice shows Stacey Friedman plans to sell 3,404 shares of JPMorgan common stock via J.P. Morgan Securities LLC on the NYSE. The filing cites an aggregate market value of about 1,042,985.11, based on the price used in the form.
The shares were granted as equity compensation on 03/25/2022, so this represents monetization of prior awards rather than an open-market purchase. The filing also lists a previous sale of 3,404 shares on 01/16/2026 with gross proceeds of 1,064,758, suggesting a structured selling pattern.
With 2,696,272,576 shares of common stock outstanding according to the notice, this proposed sale is extremely small relative to JPMorgan’s overall equity base. From a valuation standpoint it is best viewed as a routine personal liquidity event, and its impact on the stock’s supply-demand balance is likely to be negligible.
FAQ
What does the JPM (JPMorgan) Form 144 filing by Stacey Friedman disclose?
The Form 144 shows Stacey Friedman plans to sell 3,404 shares of JPMorgan common stock. The planned NYSE sale through J.P. Morgan Securities LLC reflects potential proceeds around 1,042,985.11, based on the value used in the notice, and is a routine Rule 144 resale filing.